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Summary. By inhibiting dihydrofolate reductase, metho- 
trexate (MTX) depletes cellular stores of reduced folates, 
resulting in the inhibition of DNA and RNA synthesis. In- 
hibition of RNA synthesis arrests cells in the GI phase of 
the cell cycle, preventing these cells from entering S phase 
and rendering them insensitive to MTX. Because MTX cy- 
totoxicity can be enhanced by concurrent administration 
of hypoxanthine (HX), we examined the hypothesis that 
this modulation can allow normal rates of RNA synthesis 
and cell cycle progression from G1 to S phase. For L1210 
cells exposed to MTX for 12 h or 24 h, the addition of HX 
enhanced the cytotoxicity of MTX; however, no enhance- 
ment was observed with a 6-h exposure. Inhibition of 
RNA synthesis by MTX was prevented by concurrent ad- 
ministration of HX. The effect of HX on cell cycle pro- 
gression was first examined using flow cytometry, which 
indicated that MTX treatment alone or with concurrent 
HX caused a buildup of cells with a G 1 content of DNA. 
Because this technique may fail to distinguish between 
cells in late G~ phase, the G 1 / S  border, or early S, the 
method of premature chromosome condensation was used 
to determine cell cycle position based on chromatin mor- 
phology. A shift to a higher degree of chromatin decon- 
densation was observed when HX was coadministered 
with MTX during a 12-h exposure, suggesting progression 
from GI towards S. This correlated with the enhancement 
of MTX cytotoxicity by HX after 12 h exposure. The re- 
suits of these studies suggest that HX potentiates MTX cy- 
totoxicity by maintaining RNA synthesis, allowing cells 
that might ordinarily be arrested in G~ to progress into the 
cytotoxic S phase. 
Introduction 
The anticancer agent methotrexate (MTX), through inhibi- 
tion of dihydrofolate reductase (DHFR), causes depletion 
of cellular reduced folate pools [13, 18] resuiting in inhibi- 
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tion of de novo thymidylate and purine synthesis. De- 
creased availability of thymidylate and purines contributes 
to inhibition of DNA synthesis, and the lack of purines 
causes inhibition of RNA synthesis [3]. Although inhibi- 
tion of DNA synthesis is lethal, inhibition of RNA synthe- 
sis, which is required for progression through the GI phase 
of the cell cycle, can cause cells to become arrested in this 
phase [6]. Arrest in G1 could provide protection from the 
lethal action of MTX in S phase. As a result, the action of 
MTX is self-limiting and less than maximal cytotoxicity 
may be achieved. 
The combination of MTX plus hypoxanthine (HX) has 
been shown to have increased cytotoxicity in murine and 
human tumor models [2, 15]. In mouse L cells, adenosine 
potentiated cytotoxicity as assessed by cloning in soft agar 
[2]. In both L1210 cells and two human malignant cell 
lines, various preformed purines increased MTX cytotox- 
icity at concentrations greater than 0.06 g M  MTX [15]. Be- 
cause both tumor cells and normal cells can salvage pu- 
rines for nucleic acid synthesis, the addition of preformed 
purines to MTX treatment could allow cells to use salvage 
pathways to make purine nucleotides for RNA synthesis 
[11]. We hypothesize that concurrent HX administration 
permits normal rates of RNA synthesis, resulting in pro- 
gression through GI and increased cytotoxicity. 
In the present study we have examined the ability of 
MTX plus HX to modulate the self-limiting cytotoxicity of 
MTX. For the MTX/purine combination, the data support 
the hypothesis that abrogation of the inhibition of RNA 
synthesis, along with DNA synthesis inhibition during 
MTX exposure, alleviates the arrest and protection of 
some cells in G1 by allowing continued cell cycle pro- 
gression into the more toxic S phase. 
Materials and methods 
Drugs and chemicals. MTX was kindly provided by Dr V. 
Narayanan, Chief, Drug Synthesis and Chemistry Branch, 
National Cancer Institutes, Bethesda, Md. Sendal virus 
(UV-inactivated, 2000 hemagglutinating units/0.5 ml) was 
a generous gift from Dr Walter Hittelman, Department of 
Developmental Therapeutics, The University of Texas Sys- 
tem Cancer Center, M. D. Anderson Hospital and Tumor 
Institute, Houston, Tex. RPMI 1640 medium, alpha mini- 
mum essential medium, dialyzed horse serum, calf serum, 
and Colcemid (10 Ixg/ml in Hanks'  buffered saline solu- 
tion (HBSS) with phenol red) were all obtained from Gib- 
co Laboratories, Grand Island, NY. Fetal calf serum was 
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obtained from Biofluids. Rockville, Md. (5-3H)-Uridine 
(Urd) (20 Ci/mmol) was obtained from ICN Pharmaceuti- 
cals. Irvine, Calif. 
HX (stock solution) was made just before each experi- 
ment by dissolving the compound in 10mM NaOH, 
heating at 60°C for 20 min, then diluting to 20 times the 
required concentration with RPMI 1640 medium. 
Cell culture. L1210 cells were maintained in continuous 
suspension culture in RPMI 1640 medium with 10% dia- 
lyzed horse serum as described previously [7]. The dou- 
bling time was 12 h. A CHO-KI subline of cells was grown 
in monolayer cultures in alpha minimum essential medium 
containing 10% calf serum and 5% fetal calf serum with a 
doubling time of 16 h. Both cell lines were grown in a hu- 
midified atmosphere of 5% CO 2 and 95% air at 37 ° C. 
Determination of cell viability. The soft agar cloning tech- 
nique of Chu and Fischer [4] was used to determine the vi- 
ability of L1210 cells after drug treatment. Exponentially 
growing L1210 cells were exposed to MTX with or without 
HX. After 6, 12, or 24 h of exposure, the cells were washed 
twice with fresh medium and diluted into RPMI 1640 me- 
dium containing 20% dialyzed horse serum and agar 
(0.12%) to an appropriate number, depending on the 
amount of cell kill expected. MTX is polyglutamated to 
forms that are retained in the cell after the removal of ex- 
tracellular MTX [8, 19] and therefore thymidine (dThd) 
and HX (final concentrations of 10 gM and 100 p~M, re- 
spectively) were included in the agar mixture to terminate 
the effects of MTX polyglutamates during the colony- 
forming assay. Cells were plated in triplicate and incubat- 
ed at 37 ° C in humidified 5% CO2 and 95% air. After 10-14 
days the colonies grew to about 1 mm in size and were 
counted visually. Control plating efficiency was between 
80% and 90%, which was normalized to 100% cloning effi- 
ciency. 
Measurement of RNA synthesis. Incorporation of 3H-Urd 
into acid-insoluble material was used as a measure of 
RNA synthesis according to the procedure of Mandel et 
al. [12]. L1210 cells in logarithmic growth were diluted to 
2.5 x l0 s cells/ml and MTX was added. In some cases HX 
was included at the same time. To determine RNA synthe- 
sis during the first 3 h of drug incubation, 3H-Urd was 
added at the same time as MTX and duplicate 1-ml sam- 
ples were removed and processed to assess the amount of 
radioactivity incorporated into the RNA, as described be- 
low. After 12 h of MTX exposure, RNA synthesis was de- 
termined by the addition of 3H-Urd and the removal of 
duplicate 1-ml aliquots of cell suspension at specified 
times. Each aliquot was processed as follows. The cell sus- 
pension was added to an equal volume of ice-cold 0.9% 
NaC1 solution to stop 3H-Urd incorporation and filtered 
on wetted Whatman GF/C  glass fiber disks. The cells were 
washed with 5 volumes of ice-cold 0.9% NaC1 solution, af- 
ter which the nucleic acids were precipitated with 10 vol- 
umes of 0.2 N PCA solution and the precipitate was 
washed again. The dried filters (70°C for 30 min) were 
then counted for radioactivity. 
Flow eytometry. L1210 cells were exposed to MTX for 12 h 
washed, and resuspended in cold 0.9% NaCI (2x 10 6 
cells/ml). The cells were fixed in ethanol by adding a 70% 
solution (2.5 vol.) dropwise. The fixed cells were stained 
for 20min with mithramycin (100~tg/ml) and 15 mM 
MgC12 in 25% aqueous ethanol, then examined by means 
of a FACS 4 flow cytometer (Beckton-Dickenson, Sunny- 
vale, Calif) [1, 5]. A Spectra Physics Model 164-05 argon 
ion laser at 457 nm was used to excite fluorescence. About 
1.5x 104 cells were analyzed for each DNA histogram. 
Pulse height frequency distribution histograms were nor- 
malized so that they were visually comparable. The optical 
alignment of the FACS 4 was maintained with standard 
microspheres (Coulter Electronics, Hialeah, Fla), which 
gave an average coefficient of variation of 2.1%. 
Preparation of prematurely condensed chromosomes. Pre- 
mature chromosome condensation was performed using 
the method of Hittelman and Rao [9]. L1210 cells in logar- 
ithmic growth were diluted to 2.5 x 105 cells/ml and incu- 
bated with MTX with or without HX for 6 or 12 h. Expo- 
sure times greater than 12 h with 0.5 gM MTX damaged 
the cells sufficiently to make it difficult to prepare 
prematurely condensed chromsomes (PCC). The cells were 
washed with medium and counted. Mitotic CHO cells 
were prepared by the mitotic detachment of cells at conflu- 
ency that had been treated with 0.05 gg/ml Colcemid for 
3 h. One million mitotic CHO cells were combined with 3 
million L1210 cells in 5 mM piperazine-N-N-bis(ethane- 
sulfonic acid) (PIPES) buffer at pH 7.4 and mixed thor- 
oughly. The mixture was centrifuged and resuspended in 
0.5 ml HBSS containing about 2000 hemagglutinating un- 
its of UV-inactivated Sendal virus, then left 0°C for 
15 min. Next, 50 lxl of an MgC12/Colcemid solution 
(100raM MgCI 2 and 4~tg/ml Colcemid in HBSS) was 
added to the fusing cells, and the fusion mixture was 
placed without shaking in a 37 ° C water bath for 45 min. 
After addition of 7 ml 0.075 M KC1, the cells were vor- 
texed and allowed to sit at room temperature for 12 min, 
at which time the cells were centrifuged, the KC1 solution 
poured off, and the tubes drained thoroughly. The insides 
of the tubes were wiped dry, and the cells were fixed twice 
with approximately 5 ml methanol/glacial acetic acid (3 : l, 
v/v), which was added dropwise. The fixed cells were 
dropped onto a wetted microscope slide. After air drying, 
the cells were stained for 5 min with aceto-orcein. The 
slides were coded and then scored in a blind fashion using 
a light microscope. At least 120 PCC spreads were scored 
for each treatment group. 
Results 
Cytotoxieity 
In the clonogenic studies presented here, dThd and HX 
were included in the soft agar to limit the "cytotoxic" pe- 
riod to the time during which the drug was present. If cells 
were only washed to remove extracellular MTX before 
cloning without HX and dThd, the cytotoxicity was always 
greater than when HX and dThd were present (data not 
shown). This protracted cell killing is probably due to the 
buildup and retention of cellular MTX polyglutamates 
[8, 19]. 
When L1210 cells were exposed to MTX at concentra- 
tions ranging from 0.5 ~tMto 100 l.tM for 12 h, a period of 
time equal to one cell cycle, there was a dose-dependent 
decrease in survival that plateaued at 1 ~M (Fig. 1). At this 
MTX concentration 90% of the tumor cells were rendered 
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Fig. 1. Effect of MTX exposure on cytotoxicity and its modula- 
tion by HX. L1210 cells (2 x l0 s cells/ml) were exposed to MTX 
(0.011xMto 100 gM) for 6h (O, O), 12h (D, III) or 24h (A, A) 
in the absence (open symbols) or presence (closed symbols) of 
100 IxM HX, and then cloned in medium agar containing 10 txM 
dThd plus 100 p.M HX. Colonies were counted 14 days later. The 
cloning efficiency for each treatment was determined and ex- 
pressed as a percentage of control cloning efficiency. Each point 
represents the mean + SE of at least four experiments 
MTX exposures p roduced  a one-log further reduct ion in 
clonogenic survival at 1 g M  and 100 txM MTX (signifi- 
cant ly different from MTX alone,  P <0.001, at all MTX 
concentrat ions >0.5 l.tM). In  contrast,  a 6-h exposure to 
MTX alone was less cytotoxic at a given dose than a 12-h 
exposure. This p robab ly  occurs because fewer cells are ex- 
posed to MTX in the cytotoxic S phase during a 6-h than 
during a 12-h exposure.  In addi t ion,  100 l x M H X  could not  
potent iate  MTX cytotoxicity if  the exposure was only for 
6 h, p robably  because there was insufficient t ime for cells 
to become arrested in G~. I f  the exposure per iod  was in- 
creased to 24 h, the cell kill of  MTX alone was greater 
than for the corresponding concentra t ion after a 12-h ex- 
posure,  especially at the higher MTX concentrat ions.  
However,  the addi t ion  of  100 lxM HX to the 24-h MTX ex- 
posures potent ia ted MTX cytotoxici ty at all MTX concen- 
t rat ions of  0.1 g M  or greater (significantly different than 
MTX alone;  P <0.01), al though the potent ia t ion was less 
than that seen for the same concentra t ion of  MTX after a 
12-h exposure. Thus, it appears  that L1210 cells must be 
exposed to MTX for at least one cell cycle (12 h) for HX to 
potent ia te  MTX cytotoxici ty and that this effect occurs at 
MTX concentrat ions greater than 0.05 ~tM, as HX was 
slightly protective at this or lower concentrat ions of  MTX. 
RNA synthesis 
Because an exogenous source of  preformed purines could 
provide  purine nucleotides for use in R N A  synthesis by 
way of  the salvage pathway,  we examined the abil i ty of  
HX to prevent  the inhibi t ion of  R N A  synthesis. Over the 
first 3 h of  drug exposure,  MTX produced  a dose-depen-  
dent  inhibi t ion of  incorpora t ion  of  3H-Urd into R N A  at 
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Fig. 2. Effect of HX on MTX inhibition of 3H-Urd incorporation 
into RNA. L1210 cells (2.5 × 105 cells/ml) were incubated with 0 
(O), 0.5 ~tM([2, II), or 100 lxM(Zx, &) MTX concurrently with 
10 lxM 3H-Urd in the absence (open symbol) or presence (closed 
symbols) of 100 lxMHX. At the times indicated, duplicate 1-ml ali- 
quots of cells were removed and analyzed for the amount of tri- 
tium incorporated into RNA. Results are presented as the means 
+ SE for three experiments. Control RNA synthesis was 
11.7 × 103 dpm/min per 106 cells 
sis was inhibited nearly complete ly  (100 gM) or to 20% of  
control  (0.5 txM) after 180 min. Inhibi t ion of  R N A  synthe- 
sis was main ta ined  after 12 h exposure to both MTX con- 
centrations.  HX at 100 lxM protected R N A  synthesis from 
inhibi t ion by 0.5 ~tM MTX and 100 IxM MTX over a 12-h 
per iod  (Fig. 2). Concurrent  adminis t ra t ion  of  HX and 
MTX mainta ined  R N A  synthesis at levels that  were slight- 
ly above control  synthesis, as did  HX alone. 
Cell cycle progression as measured by flow eytometry 
Flow cytometry was used to examine the abil i ty of  MTX to 
perturb cell cycle progression and the way in which HX 
might alter this effect. Figure 3 shows the results obta ined 
from flow cytometric  analysis of  cells exposed for 12 h to 
MTX or MTX plus HX. The D N A  his togram obta ined for 
cells that have been t reated with 100 lxM HX alone differs 
little from the control  D N A  histogram. However,  for cells 
t reated with 0.5 txM or 100 lxM MTX, the resulting flow 
cytograms suggest an accumulat ion of  cells in G1 and indi- 
cate loss from G2 plus M. When either concentra t ion of  
MTX was combined  with HX, the D N A  histograms pro- 
duced were similar to those seen when cells were exposed 
to MTX alone. 
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Fig. 3. DNA content histograms of L1210 cells treated with MTX 
plus HX or MTX alone. L1210 cells (2 × 105 cells/ml) were treated 
with 0.5 p.M or 100 ~tM MTX alone or concurrently with 100 ~tM 
HX for 12 h. Cells were stained with mithramycin and analyzed 
for DNA content by flow cytometry 
Cell cycle analysis by premature chromosome condensation 
Premature chromosome condensation was used to deter- 
mine the position in the cell cycle based on the deconden- 
sation state of chromatin in interphase cells. In unper- 
turbed populations there is a typical distribution of PCC 
that parallels the cell cycle as defined by cellular DNA 
content [14], and as cells progress through GI and into S 
their PCC become more decondensed [9]. This deondensa- 
tion is expressed in two ways. The first is macrodeconden- 
sation, in which the chromatids become extended and 
more narrow. The second is microdecondensation, which 
is manifest as apparent discontinuities in portions of the 
less condensed regions of the PCC. The apparent breaks in 
the PCC chromatin probably represent the unwinding of 
chromatin to such a degree that it is no longer visible un- 
der the light microscope. 
The PCC spreads were scored as to the degree of 
chromosome decondensation according to the following 
scoring system which we have described in detail previ- 
ously [7]. Figure 4 shows photomicrographs of each class. 
PCC in group 1 are a highly to moderately condensed 
form consisting of distinct unifilar structures that come 
from cells in the early to mid-G1 phase. Group 2 PCC exhi- 
bit chromatin that is more extended than in group 1 and 
contain short regions of discontinuity. The chromatin in 
group 3 is mostly discontinuous, although regions in which 
the material is linearly organized can still be seen. Groups 
2 and 3 show intermediate states of chromatin deconden- 
sation that are found in cells late in G1 or early in S phase. 
The chromatin is most highly decondensed when in S 
phase, as seen in group 4, where the PCC are very diffuse 
and disorganized. Group 4 also includes PCC containing 
short, partially replicated regions. PCC spreads that were 
completely or nearly completely bifilar were classed as G2, 
since spreads having this morphology come from cells that 
have finished replication and have initiated recondensa- 
tion in preparation for mitosis [14]. G2 PCC usually made 
up less than 10% of the total spreads and were not in- 
cluded in the scoring system. 
Figure 5 shows the distribution of PCC after treatment 
of cells with 0.5 pM MTX and/or  100 ~tM HX for 12 h. 
PCC from control and HX-treated cells were distributed 
similarly. In either case, group 2 was the class containing 
the most spreads, whereas groups 3 and 4 contained 
somewhat fewer. Statistical analysis using the chi-square 
test indicated that these two distributions were not signifi- 
cantly different from one another (P >0.1). For cells ex- 
posed to MTX, group 4 contained more spreads, and there 
were fewer present in groups 1 and 2 compared with con- 
trols. This represents a shift to more decondensed mor- 
phologies, as group 4 represents the maximal level of de- 
condensation. The combination of MTX and HX resulted 
in a further increase in the number of spreads in group 4 
and the loss of spreads from groups 1 and 2, producing a 
greater shift toward decondensation, and suggests pro- 
gression through the cell cycle. After the combination of 
MTX and HX, over 80% of the spreads were found in 
groups 3 and 4. Chi-square analysis showed that the distri- 
butions from cells exposed to MTX or MTX plus HX were 
significantly different from each other as well as from con- 
trois (P < 0.001). 
When cells were exposed to 0.5 p~M MTX alone for 6 h 
or to MTX plus 100 p~M HX and then PCC made, the re- 
sulting distributions were similar to those produced from 
control or HX-treated cells (data not shown). MTX alone 
produced a small increase in the percentage of cells with 
increased decondensation, but this effect was not en- 
hanced by the simultaneous administration of HX. 
Discussion 
MTX is known to be a cell-cycle-specific yet self-limiting 
agent [20]. It has been reported that purines potentiate 
MTX cytotoxicity [5, 6]. Borsa and Whitmore [5] have sug- 
gested that the inhibition of de novo purine synthesis by 
MTX caused cells to accumulate in G1, protecting them 
from the cytotoxic effects of MTX in S phase, and that the 
addition of purines circumvented the self-limiting effect. 
In this report, we show that the addition of HX to L1210 
cells during MTX exposure abrogated the inhibitory effect 
of MTX on RNA synthesis and allowed cell cycle pro- 
gression through Gl, producing enhanced cytotoxicity 
compared to MTX alone. 
For cells exposed to MTX for 12 h or longer, HX in- 
creased the cytotoxicity of MTX (Fig. 1). Flow cytometric 
analysis of cells treated with 0.5 p~M or 100 p.M MTX 
showed a buildup of cells with a GI content of DNA and a 
corresponding loss of cells from G J M  (Fig. 3). The addi- 
tion of HX with MTX did not alter the flow cytotograms. 
This is in agreement with the results reported by Taylor et 
al. [16, 17] for exposure of CCRF-CEM cells to 100 p~M 
MTX for one cell cycle. They observed that the addition of 
HX produced an increased cellular RNA content but did 
not prevent the accumulation of cells in G1 as measured by 
DNA-content histograms. Because flow cytometry proba- 
bly cannot distinguish between cells in late G~ (at the bor- 
der of G1 and S) and in early S phase, we used the tech- 
nique of premature chromosome condensation to deter- 
mine cell cycle progression based on chromatin morpholo- 
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Fig. 4. Photomicrographs of PCC decondensation groups of L1210 cells showing various degrees of chromatin decondensation, which 
was used to assign PCC spreads to groups 1-4. Each group is described in the Results section. The darkly stained chromosomes seen in 
each panel are the mitotic CHO cell chromosomes. 
gy. Our studies showed that  in the presence of  inhibi t ion of  
D N A  synthesis by MTX, chromat in  decondensa t ion  con- 
t inues (Fig. 5). Addi t ion  of  HX during the 12-h (one cell 
cycle) exposure to MTX increased the propor t ion  of  cells 
with higher decondensa t ion  states. These results indicate 
that  HX, by mainta in ing R N A  synthesis in the presence of  
MTX, allows the progression of  cells through G1 toward  S 
phase and results in enhanced toxicity as demonst ra ted  
here and by others [2, 15-17]. 
When cells were subjected to PCC analysis after a 6-h 
exposure to MTX or MTX plus HX, the distr ibution o f  
PCC spreads was not  altered by drug t reatment  (data  not  
shown). Furthermore,  HX did not enhance the toxici ty of  
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Fig. 5. Frequency distributions of PCC decondensation groups af- 
ter exposure to 0.5 p.M MTX and/or 100 ~M HX for 12 h. After 
drug treatment, LI210 cells were fused with mitotic CHO cells to 
induce premature chromosome condensation. At least 120 spreads 
were scored for each treatment 
Hryniuk [10] also could not demonstrate potentiat ion of 
MTX toxicity after a short exposure of C C R F - C E M  cells 
to MTX. The lack of potentiat ion by HX and the failure of 
HX to promote the movement  of ceils toward lower states 
of chromatin condensat ion after 6 h of MTX exposure 
suggests that the subpopulat ion of cells (which become ar- 
rested in G~ during a 12-h MTX treatment) could not reach 
S phase after a 6-h exposure. We propose that this subpop- 
ulat ion represents a port ion of the cells that were initially 
in late S phase when purine synthesis was inhibited se- 
condary to the depletion of reduced folates. In  6 h, these 
cells would not have sufficient time to traverse G 1 even if 
HX was provided. It is only when the durat ion of MTX 
exposure is increased to 12 h or more that the subpopula- 
t ion becomes evident. Therefore, when these cells are pro- 
vided with a source of preformed purines, they can tra- 
verse G~ and enter S phase, where they undergo thymine- 
less death. 
When cells were exposed to either 0.5 .aM or 100 ,aM 
MTX for 12 h about 10% of the cells remained clonogenic. 
The addit ion of HX reduced the number  of clonogenic 
cells to about 1%, which indicates that as many as 9% of 
the cells were arrested in G~ when treated with MTX alone. 
This is consistent with the results from the PCC studies, 
which showed a 13% decrease in the number  of cells in G~ 
(groups 1 and 2 in Fig. 5) when HX was added to the MTX 
treatment. However, after a 24-h exposure to 0.5 ,aM and 
100 ,aM MTX, only 6% or 0.3% of the cells remained clon- 
ogenic, respectively. This level of survival is in the same 
range as that observed for 12 h of MTX plus HX, suggest- 
ing that cells arrested in G1 retain their clonogenic poten- 
tial for 12 h, but if exposed to MTX for an addit ional  12 h 
most of the cells are irreversibly damaged. Addit ion of HX 
to MTX during the 24 h treatment resulted in a further de- 
crease in the clonogenicity, particularly at the higher MTX 
concentrat ions (0.5-100 lxM). This suggests that even after 
31 
a 24-h exposure, some of the cells arrested in G~ in the ab- 
sence of HX remain clonogenic during this longer period 
of exposure. It is also possible that some of the highly re- 
sistant populat ion could be made up of cells that are inher- 
ently resistant to MTX owing to increased D H F R  or de- 
creased MTX transport. 
In summary, these studies show that the self-limiting 
aspect of MTX that occurs during 12-h (one cell cycle) ex- 
posure can be overcome by providing preformed pruines 
and allowing cell cycle progression. It is only through 
sparing RNA synthesis in the presence of inhibi t ion of 
D N A  synthesis that maximal MTX cytotoxicity is 
achieved. 
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